8th Sep 2017 16:27
Arix Bioscience plc announces participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on 10-12 September 2017
LONDON, 8 September 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience", or "the Company"), a global healthcare and life science company supporting medical innovation, will present at the 19th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on 10-12 September 2017 at the Lotte New York Palace Hotel in New York City, and the Arix Bioscience presentation is on 12 September at 10:00am Eastern time / 3:00pm BST.
Jonathan Peacock, Chairman of Arix Bioscience, will provide an overview of the Company's business during the live presentation and will participate in one-on-one meetings with investors who are registered to attend the conference.
The presentation will be webcast live. To access the webcast, please visit http://wsw.com/webcast/rrshq27/arix/index.aspx. The webcast replay will remain available for 90 days following the live presentation.
For more information, please contact:
Arix Bioscience plc
Joe Anderson, CEO
+44 (0) 20 7290 1052
Matthew Cole, Communications Director
+44 (0) 20 7290 1065
Consilium Strategic Communications
Mary-Jane Elliott, Jessica Hodgson, Ivar Milligan
+44 (0)20 3709 5700
About Arix Bioscience plc
Arix Bioscience plc is a global healthcare and life science company supporting medical innovation. Headquartered in London and with an office in New York, Arix Bioscience sources, finances and builds world class healthcare and life science businesses addressing medical innovation at all stages of development. Operations are supported by privileged access to breakthrough academic science and strategic relationships with leading research accelerators and global pharmaceutical companies.
Arix Bioscience plc is listed on the Main Market of the London Stock Exchange.
For further information, please visit www.arixbioscience.com
Related Shares:
ARIX.L